Monthly Archives: February 2020
Phaco Training: OCS-01 shows clinical proof of concept in DME treatment
Phase 2 data for OCS-01, a proprietary topical nanoparticle formulation of dexamethasone from Oculis to treat patients with diabetic macular edema, demonstrated clinical proof of concept as a topical drug and greater efficacy than vehicle in reducing central macular thickness and improving visual acuity. Pravin U. Dugel, MD, presented positive data for OCS-01 at Bascom Palmer Eye Institute’s… Read More »